Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases
Authors:
- Marta Sanchez MartelesMMMarta Sanchez Marteles
- Elisa Bermejo SáizESElisa Bermejo Sáiz
- Sandra Serrano MartínezSMSandra Serrano Martínez
- Fernando Ruiz LaiglesiaFLFernando Ruiz Laiglesia
- José A. Nieto RodríguezJRJosé A. Nieto Rodríguez
- Juan I. Pérez-CalvoJPJuan I. Pérez-Calvo
- 1 April 2011
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 22 (2) , 167-171
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Diagnostic and Prognostic Utility of Brain Natriuretic Peptide in Subjects Admitted to the ICU With Hypoxic Respiratory Failure Due to Noncardiogenic and Cardiogenic Pulmonary EdemaChest, 2007
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Brain Natriuretic Peptide in the Management of Heart FailureChest, 2004
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonaleRespiratory Medicine, 1999
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.Heart, 1993
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990